Combined Use of Anakinra, Etanercept, and BETA-2 Score Linked With Improved Islet Cell Transplant Outcomes Combined Use of Anakinra, Etanercept, and BETA-2 Score Linked With Improved Islet Cell Transplant Outcomes

In a single center ' s 20-year experience, patients with sustained graft survival were more likely to have had combination treatment with anakinra plus etanercept and a BETA-2 score of 15 or higher within 1 year, researchers say.Reuters Health Information
Source: Medscape Transplantation Headlines - Category: Transplant Surgery Tags: Diabetes & Endocrinology News Source Type: news